The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

The new breast cancer screening guidelines are not enough to save Black women

A breast surgical oncologist and breast radiologist weigh in

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

The U.S. Preventive Services Task Force’s new guidelines to offer mammography from age 40 will save many lives.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Vivian Jolley Bea, MD
Chief, Breast Surgical Oncology,
Director, Breast Program, New York Presbyterian Brooklyn Methodist Hospital; Assistant professor of surgery, Weill Cornell Medicine
Kemi Babagbemi, MD
Vice chair, Diversity, Equity, and Inclusion,
Department of Radiology, Associate professor of clinical radiology, Weill Cornell Medicine; Associate attending radiologist, New York-Presbyterian Hospital
Table of Contents

YOU MAY BE INTERESTED IN

Cancer Policy

Legislation to increase access to breast and cervical cancer screening introduced in the Senate

Legislation aimed at increasing access to breast and cervical cancer screening was introduced May 22 in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services, or SCREENS, for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program, or NBCCEDP, for fiscal years 2026 through 2030. 
Drugs & Targets

Cardiac CT scanner receives FDA clearance

Arineta, a provider of cardiovascular imaging solutions, announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from FDA for low-dose lung cancer screening. This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.
Clinical Roundup

Quest Diagnostics report shows oncologists see more advanced cancers, say current tests not catching recurrence early enough

According to a recent report, “The Cancer Paradox: Oncologists’ Perspectives on Barriers to Advanced Cancer Care and Recurrence Monitoring,” oncologists believe they are seeing more and more patients with advanced cancers, and that screening barriers are the leading reason why. They worry that current tests may not catch cancer recurrence early enough.
Byline
Vivian Jolley Bea, MD
Chief, Breast Surgical Oncology,
Director, Breast Program, New York Presbyterian Brooklyn Methodist Hospital; Assistant professor of surgery, Weill Cornell Medicine
Kemi Babagbemi, MD
Vice chair, Diversity, Equity, and Inclusion,
Department of Radiology, Associate professor of clinical radiology, Weill Cornell Medicine; Associate attending radiologist, New York-Presbyterian Hospital
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account